Dr. Robert Carnahan Professor Vanderbilt U. Medical Center

Dr. Robert Carnahan is a Professor in Pediatrics and the Associate Director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center. His expertise is in the discovery of novel antibody therapeutics and rapid pandemic response platforms. In particular, he has guided the DARPA-funded Pandemic Prevention Platform (P3) program at VUMC. The goal of this program was to define and test rapid response platforms for viral pandemics. This platform was activated to respond to SARS-CoV-2 in 2020 and developed a large panel of potential antibody therapeutics, some of which have received Emergency Use Authorization in the United States and beyond. Dr. Carnahan is also a recognized expert in Lean Laboratory management practices. He has not only developed and implemented Lean Lab strategies within the Vaccine Center, but has served as a consultant and an invited speaker on this topic across the US.

Presenting at:

All times are presented in the host university’s local time zone.

Wednesday, October 26, 2022

Preparing for Pandemic Threats in a Rapidly Changing World
(9:35am - 10:20am)

You are now leaving the website that is under the control and management of DARPA. The appearance of hyperlinks does not constitute endorsement by DARPA of non-U.S. Government sites or the information, products, or services contained therein. Although DARPA may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.

After reading this message, click  to continue immediately.

Go Back